Akihiko Amano
Kurashiki, 7108602, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Transbronchial cryobiopsy for diagnosing pulmonary hyalinizing granuloma: a case report.
Journal: BMC pulmonary medicine
Published: September 12, 2025
Anti-Ro-52 antibody is a risk factor for recurrence in interstitial lung disease with positive anti-aminoacyl tRNA synthetase antibody: a single-center, retrospective observational study.
Journal: BMC pulmonary medicine
Published: August 14, 2025
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression.
Journal: Anticancer research
Published: July 08, 2025
Flexible bronchoscopic cryoablation as definitive treatment for endobronchial hamartoma: A case report.
Journal: Respiratory medicine case reports
Published: May 26, 2025
Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer.
Journal: Cancer research communications
Published: March 19, 2025
Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression.
Journal: Translational lung cancer research
Published: December 25, 2024
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan.
Journal: Translational lung cancer research
Published: December 04, 2024
Comparative analysis of first-line treatment in NSCLC including unresectable stage III (IIIB/IIIC) and stage IV with low PD-L1 expression: Clinical trial eligible versus ineligible patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 06, 2024
Risk factors for the onset of pneumothorax in idiopathic pulmonary fibrosis.
Journal: Respiratory investigation
Published: October 04, 2024
Regimen Selection for Chemoimmunotherapy in Nonsquamous Non-Small Cell Lung Cancer with Low PD-L1 Expression: A Multicenter Retrospective Cohort Study.
Journal: Clinical lung cancer
Published: August 25, 2024
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study.
Journal: Cancer research and treatment
Published: August 07, 2024
The clinical question of mepolizumab in the long-term treatment of idiopathic chronic eosinophilic pneumonia; how long should we use mepolizumab?
Journal: Respiratory medicine case reports
Published: July 25, 2024
Last Updated: 09/26/2026